MarkWide Research

Sale!

Stroke Management Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Stroke Management Market size valued at over USD 31 billion in 2020 and is anticipated to grow at a CAGR of more than 6% between 2021 and 2027. With increasing product development activities and growing awareness among the population, the market will witness lucrative growth in the coming years.
Growing geriatric population base and increasing prevalence of cardiovascular diseases will majorly drive the stroke management market expansion. In Europe, 56% of patients diagnosed with aortic valve stenosis were aged over 70 years. Moreover, several government organizations have initiated awareness programs to reduce frequency of stroke among elderly population. For instance, in the U.S., the Patient Protection and Affordable Care Act (ACA) offers health coverage to more than 20 million citizens including the elderly.
Innovations in stroke management devices along with rising demand for cardiac surgeries will augment the market progression. Some of the key players in market are focusing on development of novel stroke treatment products. For instance, Terumo Corporation announced about the product clearance by the U.S. FDA for its SOFIA catheter developed for distal navigation and successful revascularization of patients. Commercialization of such advanced interventional devices enable faster patient recovery.
Stroke management market has experienced slightly negative impact during the pandemic. In March 2020, nearly 28% visits to the emergency department for stroke management was decreased in Italy due to hospital avoidance of stroke patients and stay-at-home appeal. However, the patients suffering from cerebrovascular and neurovascular diseases are subject to high risk of COVID-19 infection. Thus, the adoption rate of stroke management devices is expected to spur significantly in the coming years.

Growing prevalence of ischemic stroke among geriatric population will offer several growth opportunities

Ischemic segment dominated more than 80% of the stroke management market share in 2020. According to the World Stroke Organization, around 60% of new cases related to ischemic stroke occur in individuals till the age 70 years globally. In addition, several market leaders are involved in development of devices to treat ischemic stroke. Medtronic launched Solitaire X, a revascularization device for treatment of acute ischemic stroke.

Several advantages associated with CT scans over other imaging modalities is set to foster the industry growth

Diagnostic devices segment in the stroke management market is slated to showcase 5.9% growth rate through 2027. Among diagnostic devices, computed tomography scan (CT scan) accounted for highest revenue share in 2020. CT scan helps in early diagnosis of diseases. Thus, continuous advancement in CT scanners for better visualization is projected to boost the segment growth during the forecast period.

Rising preference of patients towards hospitals for stroke-related assistance will fuel the market demand

Hospitals segment is estimated to reach USD 18 billion by 2027. High spending capacity of hospitals on innovative devices coupled with presence of skilled expertise is a primary factor impelling the segment revenue. Adding to this, increasing number of patient visits to multispecialty as well as small-sized hospitals will stimulate the segment value.

Increasing prevalence of stroke will continue to strengthen the industry expansion in North America region

North America stroke management market accounted for over 32% of revenue share in 2020 owing to the growing prevalence of cardiac diseases. As per the Centers for Disease Control and Prevention, every year more than 795,000 people in the U.S. suffer from stroke. Further, growing incidence of obesity, changing lifestyle, and unhealthy dietary habits add to risk factors of stroke. Additionally, high spending capacity and increasing R&D will positively impact the regional growth.

Product innovations and partnerships to widen offerings are assisting the firms in business expansion

The global stroke management market consists of several players including Abbott, Asahi Intecc CO., LTD, Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Medtronic, Penumbra, Inc. and Siemens AG among others. These companies are adopting several expansion and growth strategies such as partnerships, acquisitions and product launches to increase their market presence.

Some of the recent industry developments:

  • In September 2020, Johnson & Johnson announced the launch of Cerenovus Stroke Solutions that includes a suite of three devices intended to assist physicians in clot removal procedures. This product launch helped the company in strengthening its stroke management product portfolio and generating significant revenue.
  • In April 2019, Medtronic announced the launch of Solitaire X, a revascularization device use in patients for the treatment of acute ischemic stroke. This product launch helped the company to expand its product portfolio.

The stroke management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Type

  • Ischemic
  • Hemorrhagic
  • Transient Ischemic Attack
  • Others

Market, By Application

  • Diagnostic Devices
    • Magnetic Resonance Imaging
    • Computed Tomography Scan
    • Electrocardiography
    • Carotid Ultrasound
    • Cerebral Angiography
    • Others
  • Therapeutic Devices
    • Stent Retriever
    • Surgical Clips
    • Embolic Coils
    • Flow Diverters
    • Aspiration Catheters
    • Others

Market, By End-use

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Poland
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Malaysia
    • Thailand
    • Indonesia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Qatar
    • UAE

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    Middle East and Africa (MEA)

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Stroke management industry 3600 synopsis, 2016 – 2027 (USD Million)

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Product trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Stroke management Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing preference for minimally invasive procedures

3.3.1.2    Increasing prevalence of cardiovascular diseases worldwide

3.3.1.3    Technological advancements

3.3.1.4    Rising geriatric population in developing economies

3.3.2    Industry pitfalls & challenges

3.3.2.1    Stringent regulatory framework

3.3.2.2    High cost of procedures

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By product

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Porter’s analysis

3.8    Competitive landscape, 2020

3.8.1    Company matrix analysis, 2020

3.9    PESTEL analysis

Chapter 4   Stroke Management Market, By Type

4.1    Key segment trends

4.2    Ischemic

4.2.1    Market size by region, 2016 – 2027 (USD Million)

4.3    Hemorrhagic

4.3.1    Market size by region, 2016 – 2027 (USD Million)

4.4    Transient ischemic attack

4.4.1    Market size by region, 2016 – 2027 (USD Million)

4.5    Others

4.5.1    Market size by region, 2016 – 2027 (USD Million)

Chapter 5   Stroke Management Market, By Product

5.1    Key segment trends

5.2    Diagnostic devices

5.2.1    Market size by region, 2016 – 2027 (USD Million)

5.2.2    Magnetic resonance imaging

5.2.2.1    Market size by region, 2016 – 2027 (USD Million)

5.2.3    Computed tomography scan

5.2.3.1    Market size by region, 2016 – 2027 (USD Million)

5.2.4    Electrocardiography

5.2.4.1    Market size by region, 2016 – 2027 (USD Million)

5.2.5    Carotid ultrasound

5.2.5.1    Market size by region, 2016 – 2027 (USD Million)

5.2.6    Cerebral angiography

5.2.6.1    Market size by region, 2016 – 2027 (USD Million)

5.2.7    Others

5.2.7.1    Market size by region, 2016 – 2027 (USD Million)

5.3    Therapeutic devices

5.3.1    Market size by region, 2016 – 2027 (USD Million)

5.3.2    Stent retriever

5.3.2.1    Market size by region, 2016 – 2027 (USD Million)

5.3.3    Surgical clips

5.3.3.1    Market size by region, 2016 – 2027 (USD Million)

5.3.4    Embolic Coils

5.3.4.1    Market size by region, 2016 – 2027 (USD Million)

5.3.5    Flow diverters

5.3.5.1    Market size by region, 2016 – 2027 (USD Million)

5.3.6    Aspiration catheters

5.3.6.1    Market size by region, 2016 – 2027 (USD Million)

5.3.7    Others

5.3.7.1    Market size by region, 2016 – 2027 (USD Million)

Chapter 6   Stroke management Market, By End-use

6.1    Key segment trends

6.2    Hospitals

6.2.1    Market size by region, 2016 – 2027 (USD Million)

6.3    Ambulatory surgery centers

6.3.1    Market size by region, 2016 – 2027 (USD Million)

6.4    Diagnostic centers

6.4.1    Market size by region, 2016 – 2027 (USD Million)

6.5    Others

6.5.1    Market size by region, 2016 – 2027 (USD Million)

Chapter 7   Stroke Management Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size by country, 2016 – 2027 (USD Million)

7.2.2    Market size by type, 2016 – 2027 (USD Million)

7.2.3    Market size by product, 2016 – 2027 (USD Million)

7.2.3.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.2.3.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.2.4    Market size by end-use, 2016 – 2027 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size by type, 2016 – 2027 (USD Million)

7.2.5.2    Market size by product, 2016 – 2027 (USD Million)

7.2.5.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.2.5.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.2.5.3    Market size by end-use, 2016 – 2027 (USD Million)

7.2.6    Canada

7.2.6.1    Market size by type, 2016 – 2027 (USD Million)

7.2.6.2    Market size by product, 2016 – 2027 (USD Million)

7.2.6.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.2.6.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.2.6.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3    Europe

7.3.1    Market size by country, 2016 – 2027 (USD Million)

7.3.2    Market size by type, 2016 – 2027 (USD Million)

7.3.3    Market size by product, 2016 – 2027 (USD Million)

7.3.3.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.3.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.4    Market size by end-use, 2016 – 2027 (USD Million)

7.3.5    Germany

7.3.5.1    Market size by type, 2016 – 2027 (USD Million)

7.3.5.2    Market size by product, 2016 – 2027 (USD Million)

7.3.5.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.5.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.5.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3.6    UK

7.3.6.1    Market size by type, 2016 – 2027 (USD Million)

7.3.6.2    Market size by product, 2016 – 2027 (USD Million)

7.3.6.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.6.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.6.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3.7    France

7.3.7.1    Market size by type, 2016 – 2027 (USD Million)

7.3.7.2    Market size by product, 2016 – 2027 (USD Million)

7.3.7.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.7.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.7.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3.8    Italy

7.3.8.1    Market size by type, 2016 – 2027 (USD Million)

7.3.8.2    Market size by product, 2016 – 2027 (USD Million)

7.3.8.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.8.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.8.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3.9    Spain

7.3.9.1    Market size by type, 2016 – 2027 (USD Million)

7.3.9.2    Market size by product, 2016 – 2027 (USD Million)

7.3.9.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.9.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.9.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3.10    Russia

7.3.10.1    Market size by type, 2016 – 2027 (USD Million)

7.3.10.2    Market size by product, 2016 – 2027 (USD Million)

7.3.10.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.10.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.10.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3.11    Poland

7.3.11.1    Market size by type, 2016 – 2027 (USD Million)

7.3.11.2    Market size by product, 2016 – 2027 (USD Million)

7.3.11.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.11.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.11.3    Market size by end-use, 2016 – 2027 (USD Million)

7.3.12    The Netherlands

7.3.12.1    Market size by type, 2016 – 2027 (USD Million)

7.3.12.2    Market size by product, 2016 – 2027 (USD Million)

7.3.12.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.3.12.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.3.12.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4    Asia Pacific

7.4.1    Market size by country, 2016 – 2027 (USD Million)

7.4.2    Market size by type, 2016 – 2027 (USD Million)

7.4.3    Market size by product, 2016 – 2027 (USD Million)

7.4.3.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.3.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.4    Market size by end-use, 2016 – 2027 (USD Million)

7.4.5    Japan

7.4.5.1    Market size by type, 2016 – 2027 (USD Million)

7.4.5.2    Market size by product, 2016 – 2027 (USD Million)

7.4.5.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.5.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.5.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4.6    China

7.4.6.1    Market size by type, 2016 – 2027 (USD Million)

7.4.6.2    Market size by product, 2016 – 2027 (USD Million)

7.4.6.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.6.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.6.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4.7    India

7.4.7.1    Market size by type, 2016 – 2027 (USD Million)

7.4.7.2    Market size by product, 2016 – 2027 (USD Million)

7.4.7.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.7.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.7.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4.8    Australia

7.4.8.1    Market size by type, 2016 – 2027 (USD Million)

7.4.8.2    Market size by product, 2016 – 2027 (USD Million)

7.4.8.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.8.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.8.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4.9    Malaysia

7.4.9.1    Market size by type, 2016 – 2027 (USD Million)

7.4.9.2    Market size by product, 2016 – 2027 (USD Million)

7.4.9.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.9.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.9.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4.10    Thailand

7.4.10.1    Market size by type, 2016 – 2027 (USD Million)

7.4.10.2    Market size by product, 2016 – 2027 (USD Million)

7.4.10.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.10.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.10.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4.11    Indonesia

7.4.11.1    Market size by type, 2016 – 2027 (USD Million)

7.4.11.2    Market size by product, 2016 – 2027 (USD Million)

7.4.11.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.11.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.11.3    Market size by end-use, 2016 – 2027 (USD Million)

7.4.12    South Korea

7.4.12.1    Market size by type, 2016 – 2027 (USD Million)

7.4.12.2    Market size by product, 2016 – 2027 (USD Million)

7.4.12.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.4.12.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.4.12.3    Market size by end-use, 2016 – 2027 (USD Million)

7.5    Latin America

7.5.1    Market size by country, 2016 – 2027 (USD Million)

7.5.2    Market size by type, 2016 – 2027 (USD Million)

7.5.3    Market size by product, 2016 – 2027 (USD Million)

7.5.3.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.5.3.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.5.4    Market size by end-use, 2016 – 2027 (USD Million)

7.5.5    Brazil

7.5.5.1    Market size by type, 2016 – 2027 (USD Million)

7.5.5.2    Market size by product, 2016 – 2027 (USD Million)

7.5.5.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.5.5.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.5.5.3    Market size by end-use, 2016 – 2027 (USD Million)

7.5.6    Mexico

7.5.6.1    Market size by type, 2016 – 2027 (USD Million)

7.5.6.2    Market size by product, 2016 – 2027 (USD Million)

7.5.6.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.5.6.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.5.6.3    Market size by end-use, 2016 – 2027 (USD Million)

7.5.7    Argentina

7.5.7.1    Market size by type, 2016 – 2027 (USD Million)

7.5.7.2    Market size by product, 2016 – 2027 (USD Million)

7.5.7.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.5.7.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.5.7.3    Market size by end-use, 2016 – 2027 (USD Million)

7.6    Middle East & Africa

7.6.1    Market size by country, 2016 – 2027 (USD Million)

7.6.2    Market size by type, 2016 – 2027 (USD Million)

7.6.3    Market size by product, 2016 – 2027 (USD Million)

7.6.3.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.6.3.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.6.4    Market size by end-use, 2016 – 2027 (USD Million)

7.6.5    South Africa

7.6.5.1    Market size by type, 2016 – 2027 (USD Million)

7.6.5.2    Market size by product, 2016 – 2027 (USD Million)

7.6.5.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.6.5.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.6.5.3    Market size by end-use, 2016 – 2027 (USD Million)

7.6.6    Saudi Arabia

7.6.6.1    Market size by type, 2016 – 2027 (USD Million)

7.6.6.2    Market size by product, 2016 – 2027 (USD Million)

7.6.6.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.6.6.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.6.6.3    Market size by end-use, 2016 – 2027 (USD Million)

7.6.7    Qatar

7.6.7.1    Market size by product, 2016 – 2027 (USD Million)

7.6.7.1.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.6.7.1.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.6.7.2    Market size by end-use, 2016 – 2027 (USD Million)

7.6.8    UAE

7.6.8.1    Market size by type, 2016 – 2027 (USD Million)

7.6.8.2    Market size by product, 2016 – 2027 (USD Million)

7.6.8.2.1    Market size by diagnostic devices, 2016 – 2027 (USD Million)

7.6.8.2.2    Market size by therapeutic devices, 2016 – 2027 (USD Million)

7.6.8.3    Market size by end-use, 2016 – 2027 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2020

8.2    Abbott

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    Asahi Intecc CO., LTD

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    B. Braun Melsungen AG

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Boston Scientific Corporation

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    GE Healthcare

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    Koninklijke Philips N.V

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Integer Holdings Corporation

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Johnson & Johnson Services Inc

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    Kaneka Medix Corp

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    Medtronic Public Limited Company

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    Penumbra, Inc

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    Siemens Healthineers AG

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis

8.14    Silk Road Medical, Inc.

8.14.1    Business overview

8.14.2    Financial data

8.14.3    Product landscape

8.14.4    Strategic outlook

8.14.5    SWOT analysis

8.15    Teleflex Incorporated

8.15.1    Business overview

8.15.2    Financial data

8.15.3    Product landscape

8.15.4    Strategic outlook

8.15.5    SWOT analysis

Data Tables

TABLE 1    Stroke management market, 2016-2020 (USD Million)

TABLE 2    Stroke management market, 2021-2027 (USD Million)

TABLE 3    Stroke management market, by type, 2016-2020 (USD Million)

TABLE 4    Stroke management market, by type, 2021-2027 (USD Million)

TABLE 5    Stroke management market, by product, 2016-2020 (USD Million)

TABLE 6    Stroke management market, by product, 2021-2027 (USD Million)

TABLE 7    Stroke management market, by end-use, 2016-2020 (USD Million)

TABLE 8    Stroke management market, by end-use, 2021-2027 (USD Million)

TABLE 9    Stroke management market, by region, 2016-2020 (USD Million)

TABLE 10    Stroke management market, by region, 2021-2027 (USD Million)

TABLE 11    Industry impact forces

TABLE 12    Ischemic market size, by region, 2016-2020 (USD Million)

TABLE 13    Ischemic market size, by region, 2021-2027 (USD Million)

TABLE 14    Hemorrhagic market size, by region, 2016-2020 (USD Million)

TABLE 15    Hemorrhagic market size, by region, 2021-2027 (USD Million)

TABLE 16    Transient ischemic attack market size, by region, 2016-2020 (USD Million)

TABLE 17    Transient ischemic attack market size, by region, 2021-2027 (USD Million)

TABLE 18    Others market size, by region, 2016-2020 (USD Million)

TABLE 19    Others market size, by region, 2021-2027 (USD Million)

TABLE 20    Diagnostic devices market size, by region, 2016-2020 (USD Million)

TABLE 21    Diagnostic devices market size, by region, 2021-2027 (USD Million)

TABLE 22    Magnetic resonance imaging market size, by region, 2016-2020 (USD Million)

TABLE 23    Magnetic resonance imaging market size, by region, 2021-2027 (USD Million)

TABLE 24    Computed tomography scan market size, by region, 2016-2020 (USD Million)

TABLE 25    Computed tomography scan market size, by region, 2021-2027 (USD Million)

TABLE 26    Electrocardiography market size, by region, 2016-2020 (USD Million)

TABLE 27    Electrocardiography market size, by region, 2021-2027 (USD Million)

TABLE 28    Carotid ultrasound market size, by region, 2016-2020 (USD Million)

TABLE 29    Carotid ultrasound market size, by region, 2021-2027 (USD Million)

TABLE 30    Cerebral angiography market size, by region, 2016-2020 (USD Million)

TABLE 31    Cerebral angiography market size, by region

Market, By Type

  • Ischemic
  • Hemorrhagic
  • Transient Ischemic Attack
  • Others

Market, By Application

  • Diagnostic Devices
    • Magnetic Resonance Imaging
    • Computed Tomography Scan
    • Electrocardiography
    • Carotid Ultrasound
    • Cerebral Angiography
    • Others
  • Therapeutic Devices
    • Stent Retriever
    • Surgical Clips
    • Embolic Coils
    • Flow Diverters
    • Aspiration Catheters
    • Others

Market, By End-use

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

bbott, Asahi Intecc CO., LTD, Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Medtronic, Penumbra, Inc. and Siemens AG among others.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF